Education
About Us
Working with TipRanks
Follow Us
medmix AG (CH:MEDX)
:MEDX
Total Valuation
medmix AG has a market cap or net worth of CHF364.76M. The enterprise value is CHF645.95M.
Market CapCHF364.76M
Enterprise ValueCHF645.95M
Share Statistics
medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,262,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
medmix AG’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.61%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.61%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee166.92K
Profits Per Employee2.38K
Employee Count2,684
Asset Turnover0.46
Inventory Turnover3.76
Valuation Ratios
The current PE Ratio of medmix AG is 71.6. medmix AG’s PEG ratio is -0.38.
PE Ratio71.6
PS Ratio1.02
PB Ratio1.08
Price to Fair Value1.08
Price to FCF13.76
Price to Operating Cash Flow5.30
PEG Ratio-0.38
Income Statement
In the last 12 months, medmix AG had revenue of 448.00M and earned 6.40M in profits. Earnings per share was 0.16.
Revenue448.00M
Gross Profit161.90M
Operating Income27.40M
Pretax Income9.00M
Net Income6.40M
EBITDA79.70M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 67.80M and capital expenditures -34.50M, giving a free cash flow of 33.30M billion.
Operating Cash Flow67.80M
Free Cash Flow33.30M
Free Cash Flow per Share0.81
Dividends & Yields
medmix AG pays an annual dividend of CHF0.5, resulting in a dividend yield of 4.54%
Dividend Per ShareCHF0.5
Dividend Yield4.54%
Payout Ratio64.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-16.13%
50-Day Moving Average11.06
200-Day Moving Average10.60
Relative Strength Index (RSI)21.68
Average Volume (3m)115.75K
Important Dates
medmix AG upcoming earnings date is Jul 16, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateJul 16, 2026
Ex-Dividend Date―
Financial Position
medmix AG as a current ratio of 1.54, with Debt / Equity ratio of 92.06%
Current Ratio1.54
Quick Ratio1.10
Debt to Market Cap0.72
Net Debt to EBITDA3.59
Interest Coverage Ratio3.04
Taxes
In the past 12 months, medmix AG has paid 2.00M in taxes.
Income Tax2.00M
Effective Tax Rate0.22
Enterprise Valuation
medmix AG EV to EBITDA ratio is 9.34, with an EV/FCF ratio of 22.36.
EV to Sales1.66
EV to EBITDA9.34
EV to Free Cash Flow22.36
EV to Operating Cash Flow10.98
Balance Sheet
medmix AG has CHF113.90M in cash and marketable securities with CHF391.90M in debt, giving a net cash position of -CHF278.00M billion.
Cash & Marketable SecuritiesCHF113.90M
Total DebtCHF391.90M
Net Cash-CHF278.00M
Net Cash Per Share-CHF6.74
Tangible Book Value Per ShareCHF1.54
Margins
Gross margin is 36.14%, with operating margin of 6.12%, and net profit margin of 1.43%.
Gross Margin36.14%
Operating Margin6.12%
Pretax Margin2.01%
Net Profit Margin1.43%
EBITDA Margin17.79%
EBIT Margin6.12%
Analyst Forecast
The average price target for medmix AG is CHF16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF16.00
Price Target Upside81.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-2.42%
EPS Growth Forecast-222.68%